USE OF THE SF-36 QUESTIONNAIRE IN ASSESSMENT OF QUALITY OF LIFE IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
https://doi.org/10.17650/1818-8338-2017-11-3-4-44-49
Abstract
Objective: to carry out a complex assessment of life quality (LQ) in patients with chronic thromboembolic pulmonary hypertension (CTEPH) according to SF-36 questionnaire.
Materials and methods. The study included 20 patients who underwent in-patient examination and treatment in City Clinical Hospital № 1 n.a. N.I. Pirogov (Moscow City Healthcare Department) to confirm the diagnosis of CTEPH and for selection of drug therapy. All patients completed a standardized SF-36 questionnaire. The possible association of various parameters of this questionnaire with both clinical and instrumental data of patient’s examination was studied.
Results. Statistically significant correlations between the clinical symptoms of the disease, the severity of pulmonary hypertension, and the assessment of the possible physical activity of patients with CTEPH with various scales of mental and physical functioning of SF-36 questionnaire have been obtained.
Conclusion. The study of QL parameters increases the possibilities for a comprehensive assessment of health status in patients with CTEPH. Based on this finding, SF-36 questionnaire can be used in routine clinical practice to assess the disease severity. Increasing the patient’s number as well as carrying out a dynamic QL study according to sex and age of patients with SF-36 questionnaire will further allow to develop additional criteria for assessing the effectiveness of therapy.
About the Authors
N. A. Shostak
Russian National Research Medical University named after N.I. Pirogov, Ministry of Health of Russia
Russian Federation
Russian Federation
1 Ostrovityanova St., Moscow 117997
A. N. Klimenko
Russian National Research Medical University named after N.I. Pirogov, Ministry of Health of Russia
Russian Federation
Russian Federation
1 Ostrovityanova St., Moscow 117997
V. S. Shemenkova
Russian National Research Medical University named after N.I. Pirogov, Ministry of Health of Russia; City Clinical Hospital № 1 named after N.I. Pirogov, Moscow City Healthcare Department
Russian Federation
Russian Federation
1 Ostrovityanova St., Moscow 117997; 8 Leninskiy Prospekt, Moscow 117049
A. V. Svet
City Clinical Hospital № 1 named after N.I. Pirogov, Moscow City Healthcare Department
Russian Federation
Russian Federation
8 Leninskiy Prospekt, Moscow 117049
References
1. Клинические рекомендации по диагностике и лечению хронической тромбоэмболической легочной гипертензии. Евразийский кардиологический журнал 2016;(2):7–27.
2. Riedel M., Stanek V., Widimsky J., Prerovsky I. Long-term follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest 1982;81(2):151–8. PMID: 7056079.
3. Kingman M., Hinzmann B., Sweet O. et al. Living with pulmonary hypertension: unique insights from an international ethnographic study. BMJ Open 2014;4(5):е004735. DOI: 10.1136/bmjopen-2013-004735. PMID: 4024598.
4. Klok F.A., van Kralingen K.W., van Dijk A.P. et al. Quality of life in longterm survivors of acute pulmonary embolism. Chest 2010;138(6):1432–40. DOI: 10.1378/chest.09-2482. PMID: 20495104.
5. Пикалова Н.Н., Мовчан Е.А. Общий опросник SF-36 в изучении физического и психологического состояния людей на программном гемодиализе. Вестник Новосибирского государственного педагогического университета 2012;3(7):86–96.
6. Cenedese E., Speich R., Dorschner L. et al. Measurement of quality of life in pulmonary hypertension and its significance. Eur Respir J 2006;28(4):808–15. DOI: 10.1183/09031936.06.00130405. PMID: 16707511.
7. Roman A., Barbera J.A., Castillo M.J. et al. Health-related quality of life in a national cohort of patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension. Arch Bronconeumol 2013;49(5):181–8. DOI: 10.1016/j.arbres.2012.12.007. PMID: 23452896.
8. Guillevin L., Armstrong I., Aldrighetti R. et al. Understanding the impact of pulmonary arterial hypertension on patients’ and carers’ lives. Eur Respir Rev 2013;22(130):535–45. DOI: 10.1183/09059180.00005713. PMID: 24293469.
9. Инструкция по обработке данных, полученных с помощью опросника SF-36. URL: http://bono-esse.ru/blizzard/RPP/sf36.pdf.
10. Amirdzhanova V.N., Goryachev L.V., Korshunov N.I. et al. Population parameters of life quality according to the questionnaire SF-36 (results of the multicentre study of life quality «MIRAGE»). Nauchno-prakticheskaya revmatologiya = Scientific and Practical Rheumatology 2008;(1):36–48. (In Russ.).
11. Kukkonen M., Puhakka A., Halme M. Quality of life among pulmonary hypertension patients in Finland. Eur Clin Respir J 2016;3:26405. DOI: 10.3402/ecrj.v3.26405. PMID: 26787306.
12. van Es J., den Exter P.L., Kaptein A.A. et al. Quality of life after pulmonary embolism as assessed with SF-36 and PEmbQoL. Thromb Res 2013;132(5):500–5. DOI: 10.1016/j.thromres.2013.06.016. PMID: 24090607.
Review
For citations:
Shostak N.A., Klimenko A.N., Shemenkova V.S., Svet A.V. USE OF THE SF-36 QUESTIONNAIRE IN ASSESSMENT OF QUALITY OF LIFE IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION. The Clinician. 2017;11(3-4):44-49. (In Russ.) https://doi.org/10.17650/1818-8338-2017-11-3-4-44-49
Views:
1170
Email this article 